The Eunice Kennedy Shriver National Institute of Child Health and Human Development Surfactant, Positive Pressure and Pulse Oximetry Randomized Trial (SUPPORT) 1 compared the effect of oxygen saturation targets on retinopathy of prematurity or death among infants born at 24 to 27 weeks' gestational age. One thousand three hundred sixteen infants were randomized to lower (85%-89%) vs higher (91%-95%) target oxygen saturation. Rates of severe retinopathy of prematurity or death were not different (28.3% and 32.1%, respectively; relative risk with lower target, 0.90; 95% CI, 0.76-1.06; P = .21). Lower oxygen targets reduced severe retinopathy of prematurity among survivors (8.6% vs 17.9%; relative risk, 0.52; 95% CI, 0.37-0.73; P < .001). However, an unanticipated and unexplained finding was increased mortality in the lower saturation group (19.9% vs 16.2%; relative risk, 1.27; 95% CI, 1.01-1.60; P = .04). The study included neurodevelopmental assessment at 2 years of age; at that assessment we noted a disproportionate loss of small for gestational age (SGA) infants. This observation promoted us to assess whether there was an interaction between oxygen target group and growth status.
Methods | Methods and outcomes of SUPPORT have been reported previously. 1 The study was approved by the institutional review boards at all participating institutions, and parents gave written informed consent for enrollment prior to delivery. In this post hoc analysis, we compared survival rates and causes between SGA (<10% on the Olsen curves) 2 and appropriate for gestational age (AGA) infants by assigned target saturation groups using Kaplan-Meier survival analyses. We repeated the analyses in the original cohort using Poisson regression in a generalized estimating equations model that controlled for stratification by clinical center, gestational age strata (24 0/7 to 25 6/7 weeks vs 26 0/7 to 27 6/7 weeks), and familial clustering (as multiple births were randomized to the same treatment group) with the addition of a term-testing interaction between the randomized oxygen target group and growth status.
Results | Of the 1316 infants enrolled in SUPPORT, 237 infants died (Table) . Thirty-seven of 96 SGA infants (38.5%) died, while 200 of 1220 AGA infants (16.4%) died (P < .01). Mortality did not differ significantly for AGA infants between both saturation groups (lower target 17.6% vs higher target 15.2%; P = .17).
In contrast, SGA infants had more than twice the mortality in the lower vs the higher target group (lower target 56.1% vs higher target 25.5%; P < .01; interaction term P = .06) (Figure) . Severe retinopathy of prematurity was reduced in the lower saturation group in AGA infants (8.5% vs 16.5%; relative risk 0.55; 95% CI, 0.30-0.78; P < .001), with a numerical difference in the SGA survivors that did not reach statistical significance (12.5% v 35.1%; relative risk 0.59; 95% CI, 0.17-2.07; P = .41). The leading causes of death in the AGA infants were respiratory distress syndrome and infection, while the leading causes of death in SGA infants were respiratory distress syndrome and bronchopulmonary dysplasia. There was no difference in mortality from necrotizing enterocolitis (14% SGA vs 16% AGA).
Discussion | This post hoc study found evidence of an interaction between SGA infants and lower oxygen targets associated with increased mortality, which, to our knowledge, has not been reported before. Appropriate for gestational age infants did not experience the same mortality in the lower Higher target Lower target A, Small for gestational age infants randomized to the lower oxygen target (shown in tan) had significantly poorer survival than those randomized to the higher oxygen target (shown in blue). B, Appropriate for gestational age infants had similar mortality between the 2 oxygen strata. Based on epidemiologic data from respiratory virus testing at CHCO, the EV-D68 outbreak period was defined as August 1 through September 30, 2014 ( Figure 1) . This is an observational retrospective time series study comparing observed resource utilization during the defined 2014 EV-D68 outbreak period vs expected values forecasted from historical data. Monthly resource utilization data were collected through the CHCO infectious disease data warehouse. Respiratory patient volumes include children with International Classification of Diseases, Ninth Revision codes within major diagnostic category 4 (diseases and disorders of the respiratory system). Days of therapy (DOT) reflect documented administration of a medication or treatment on a calendar day in the electronic medical record. Direct patient care services delivered by respiratory therapists were converted into units of service (UOS) using Children's Hospital Association Pediatric Analysis and Comparison Tool criteria. This study Letters 
Resource Burden

